Search Results

Filter
  • 1-10 of  5,725 results for ""PARTIAL thromboplastin time""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

An ex vivo comparison of partial thromboplastin time and activated clotting time for heparin anticoagulation in an ovine model.

  • Authors : Berk ZBK; Department of Surgery, Division of Cardiac Surgery, University of Maryland School of Medicine, Baltimore, Maryland, USA.; Shah A

Subjects: Partial Thromboplastin Time* ; Whole Blood Coagulation Time*; Anticoagulants/Anticoagulants/Anticoagulants/*administration & dosage

  • Source: Artificial organs [Artif Organs] 2022 Mar; Vol. 46 (3), pp. 501-505. Date of Electronic Publication: 2021 Nov 02.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7802778 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Activated Partial Thromboplastin Time Versus Anti-Factor Xa Monitoring of Heparin Anticoagulation in Adult Venoarterial Extracorporeal Membrane Oxygenation Patients.

  • Authors : Kulig CE; University of California, Davis Medical Center, Sacramento, California.; Schomer KJ

Subjects: Extracorporeal Membrane Oxygenation* ; Partial Thromboplastin Time*; Anticoagulants/Anticoagulants/Anticoagulants/*administration & dosage

  • Source: ASAIO journal (American Society for Artificial Internal Organs : 1992) [ASAIO J] 2021 Apr 01; Vol. 67 (4), pp. 411-415.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9204109 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Report

Discordance in activated partial thromboplastin time and anti-factor Xa levels in COVID-19 patients on heparin therapy.

  • Authors : Lawlor M; Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center, 630 W 168th St, New York, NY 10032, United States oF America.; Gupta A

Subjects: Partial Thromboplastin Time* ; COVID-19 Drug Treatment*; Blood Coagulation/Blood Coagulation/Blood Coagulation/*drug effects

  • Source: Thrombosis research [Thromb Res] 2021 Feb; Vol. 198, pp. 79-82. Date of Electronic Publication: 2020 Nov 28.Publisher: Pergamon Press Country of Publication: United States NLM ID: 0326377 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Evaluation of Anti-Xa and Activated Partial Thromboplastin Time Monitoring of Heparin in Adult Patients Receiving Extracorporeal Membrane Oxygenation Support.

  • Authors : Arnouk S; From the Department of Pharmacy, NYU Langone Health, New York, New York.; Altshuler D

Subjects: Partial Thromboplastin Time*; Anticoagulants/Anticoagulants/Anticoagulants/*administration & dosage ; Extracorporeal Membrane Oxygenation/Extracorporeal Membrane Oxygenation/Extracorporeal Membrane Oxygenation/*adverse effects

  • Source: ASAIO journal (American Society for Artificial Internal Organs : 1992) [ASAIO J] 2020 Mar; Vol. 66 (3), pp. 300-306.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9204109 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Correlation Among Antifactor Xa, Activated Partial Thromboplastin Time, and Heparin Dose and Association with Pediatric Extracorporeal Membrane Oxygenation Complications.

Subjects: Partial Thromboplastin Time*; Anticoagulants/Anticoagulants/Anticoagulants/*administration & dosage ; Extracorporeal Membrane Oxygenation/Extracorporeal Membrane Oxygenation/Extracorporeal Membrane Oxygenation/*adverse effects

  • Source: ASAIO journal (American Society for Artificial Internal Organs : 1992) [ASAIO J] 2020 Mar; Vol. 66 (3), pp. 307-313.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9204109 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

The accuracy of a point of care measurement of activated partial thromboplastin time in intensive care patients.

  • Authors : Karigowda L; Department of Intensive Care, St George Hospital, Kogarah, NSW, Australia. Electronic address: .; Deshpande K

Subjects: Partial Thromboplastin Time* ; Point-of-Care Systems*; Anticoagulants/Anticoagulants/Anticoagulants/*therapeutic use

  • Source: Pathology [Pathology] 2019 Oct; Vol. 51 (6), pp. 628-633. Date of Electronic Publication: 2019 Aug 21.Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 0175411 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Monitoring Unfractionated Heparin: A Review of Activated Partial Thromboplastin Time Versus Antifactor Xa.

  • Authors : Parker CR; Christine R. Parker is Clinical Pharmacy Specialist, Cardiothoracic Intensive Care Unit, Baylor University Medical Center, 3500 Gaston Ave, Dallas, TX 75246, (). Vivek Kataria is Clinical Pharmacy Specialist, Medical Intensive Care Unit, Baylor University Medical Center, Dallas, Texas.; Kataria V

Subjects: Partial Thromboplastin Time*; Anticoagulants/Anticoagulants/Anticoagulants/*therapeutic use ; Biological Monitoring/Biological Monitoring/Biological Monitoring/*standards

  • Source: AACN advanced critical care [AACN Adv Crit Care] 2019 Dec 15; Vol. 30 (4), pp. 305-312.Publisher: American Association of Critical-Care Nurses (AACN) Country of Publication: United States NLM ID: 101269322 Publication Model: Print Cited

Record details

×
Academic Journal

Partial thromboplastin time is more predictive of bleeding than anti-Xa levels in heparinized pediatric patients after cardiac surgery.

  • Authors : Oladunjoye OO; Department of Cardiovascular Surgery, Boston Children's Hospital, Boston, Mass.; Sleeper LA

Subjects: Partial Thromboplastin Time*; Anticoagulants/Anticoagulants/Anticoagulants/*adverse effects ; Blood Coagulation/Blood Coagulation/Blood Coagulation/*drug effects

  • Source: The Journal of thoracic and cardiovascular surgery [J Thorac Cardiovasc Surg] 2018 Jul; Vol. 156 (1), pp. 332-340.e1. Date of Electronic Publication: 2018 Apr 04.Publisher: Mosby Country of Publication: United States NLM ID: 0376343 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-685X

Record details

×
Academic Journal

Comparison of Antifactor Xa and Activated Partial Thromboplastin Time Monitoring for Heparin Dosing in Vascular Surgery Patients: A Single-Center Retrospective Study.

  • Authors : Rizk E; Department of Pharmacy, Houston Methodist Hospital, Houston, Texas.; Wilson AD

Subjects: Partial Thromboplastin Time*; Factor Xa Inhibitors/Factor Xa Inhibitors/Factor Xa Inhibitors/*blood ; Heparin/Heparin/Heparin/*adverse effects

  • Source: Therapeutic drug monitoring [Ther Drug Monit] 2018 Feb; Vol. 40 (1), pp. 151-155.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 7909660 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Agreement between activated partial thromboplastin time and anti-Xa activity in critically ill patients receiving therapeutic unfractionated heparin.

  • Authors : Ratano D; Service of Intensive Care and Burn Unit, Lausanne University Hospital (CHUV) and Faculty of Biology & Medicine, University of Lausanne, Lausanne, Switzerland. Electronic address: .; Alberio L

Subjects: Anticoagulants/Anticoagulants/Anticoagulants/*blood ; Factor Xa Inhibitors/Factor Xa Inhibitors/Factor Xa Inhibitors/*therapeutic use ; Heparin/Heparin/Heparin/*blood

  • Source: Thrombosis research [Thromb Res] 2019 Mar; Vol. 175, pp. 53-58. Date of Electronic Publication: 2019 Jan 07.Publisher: Pergamon Press Country of Publication: United States NLM ID: 0326377 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  5,725 results for ""PARTIAL thromboplastin time""